Nowojewski, Andrzej http://orcid.org/0009-0005-7729-8452
Bark, Erik
Shih, Vivian H. http://orcid.org/0000-0003-0853-4210
Dearden, Richard
Article History
Accepted: 29 February 2024
First Online: 10 April 2024
Declarations
:
: All authors are or were employees and shareholders of AstraZeneca at the time of study conduct.
: The details of the design and results of the OSTRO, NAVIGATOR, and SOURCE trials have been previously reported (ClinicalTrials.gov Identifiers: NCT03401229 [CitationRef removed], NCT03347279 [CitationRef removed], and NCT03406078 [CitationRef removed]). The protocols were approved by the independent ethics committee at each participating site, and all patients provided written informed consent. A review process was followed that ensured that the proposed analysis was within the scope of original approvals and signed informed consent forms (INT-20211208–893, 8 December 2021). This study used existing fully de-identified data and the investigators or patients could not be identified, directly or through identifiers linked to patients.